Natural protease inhibitors to hemorrhagins in snake venoms and their potential use in medicine

Toxicon

Volumn 37, Issue 5, 1999, Pages 703-728

  Pérez, John C ^a   Sánchez, Elda E ^a  

^a TEXAS A AND M UNIVERSITY KINGSVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; MATRIX METALLOPROTEINASE; PROTEINASE; PROTEINASE INHIBITOR; SNAKE VENOM ANTISERUM; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL EXPERIMENT; BLEEDING; ENVENOMATION; IMMUNITY; MOUSE; NONHUMAN; OPOSSUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN ISOLATION; RAT; REVIEW; SPECIES;

ANIMALS; HEMORRHAGE; METALLOENDOPEPTIDASES; SNAKE VENOMS; TISSUE INHIBITOR OF METALLOPROTEINASES;

ANIMALIA; MAMMALIA; SERPENTES;

EID: 0344527842     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-0101(98)00205-0     Document Type: Review

References (116)

1. Ahmed N.K., Tennant K.D., Markland F.S., Lacz J.P. Biochemical characteristics of fibrolase, a fibrinolytic protease from snake venom. Haemostasis. 20:1990;147-154.
2. Austad S.N. The adaptable opossum. Scientific American. 258:1988;98-104.
3. Baker B.J., Tu A.T. Atroxase-a fibrinolytic enzyme isolated from the venom of Western diamondback rattlesnake. Isolation, characterization and cloning. Advances in Experimental Medicine and Biology. 391:1996;203-211.
4. Basbaum C.B., Werb Z. Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr. Opin. Cell. Biol. 8:1996;731-738.
5. Billard G. Immunite du lerot commun (Eliomys nitela) contre le venin de la vipere. C. R. Seanc. Soc. Biol. 67:1909;90.
6. Billard G. Immunite naturelle du lerot apres hibernation, et immunite naturelle du blaireau contre le venin de la vipere. C. R. Seanc. Soc. Biol. 68:1910;982.
7. Birkedal-Hansen H. Proteolytic remodeling of extracellular matrix. Curr. Opin. Cell. Biol. 7:1995;728-729.
8. Bjarnason J.B., Fox J.W. Hemorrhagic metalloproteinases from snake venoms. Pharmac. Ther. 62:1994;325-372.
9. Blobel C.P., Wolfsberg T.G., Turck C.W., Myles D.G., Primakoff P., White J.M. A potential fusion peptide and an integrin ligand domain in a protein active in sperm-egg fusion. Nature. 356:1992;248-252.
10. Bonnet D.E., Guttman S.I. Inhibition of moccasin (Agkistrodon piscivorus) venom proteolytic activity by the serum of the Florida kingsnake (Lampropeltis getulus floridana). Toxicon. 9:1971;417.
11. Botos I., Scapozza L., Zhang D., Liotta L.A., Meyer E.F. Batimastat, a potent matrix metalloproteinase inhibitor, exhibits an unexpected mode of binding. Proc. Natl. Acad. Sci. USA. 93:1996;2749-2754.
12. Brooks P.C., Strombald S., Sanders L.C., von Schalscha T.L., Aimes R.T., Stetler-Stevenson W.G., Quigley J.P., Cheresh D.A. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell. 85:1996;683-693.
13. Brokow G., Gutierrez J.M., Ovadia M. Inhibition of the hemorrhagic activity of Bothrops asper venom by a novel neutralization mixture. Toxicon. 35:1997;865-877.
14. Bücherl, W., Buckley, E., Deulofeu, V., 1968. Venomous Animal and their Venoms, vol. I. Academic Press, New York.
15. Burton, M., 1969. The Hedgehog. The Trinity Press, Worcester, p. 42.
16. Calmette, A., 1907. Les Venins. Masson, Paris, ch. 11.
17. Catanese J.J., Kress L.F. Isolation from opossum serum of a metalloproteinase inhibitor homologous to human α1-β glycoprotein. Biochemistry. 31:1992;410-418.
18. Catanese J.J., Kress L.F. Opossum serum α1-proteinase inhibitor: purification, linear sequence and resistance to inactivation by rattlesnake venom metalloproteinases. Biochemistry. 32:1993;509-515.
19. Chambers A.F., Matrisian L.M. Changing view of the role of matrix metalloproteinases in metastasis. Journal of the National Cancer Institute. 89:1997;1260-1270.
20. Chen W.T. Membrane proteases: roles in tissue remodeling and tumour invasion. Curr. Opin. Cell. Biol. 4:1992;802-809.
21. Clark W.C., Voris A.K. Venom neutralization by rattlesnake serum albumin. Science. 164:1969;1402-1404.
22. Cohn J.P. Beyond the lab rat; what biomedicine is learning from unconventional organisms. BioScience. 39:1989;518-522.
23. Coric P., Turcaud S., Meudal H., Roques B.P., Fournie-Zaluski M.C. Optimal recognition of neutral endopeptidase and angiotensin-converting enzyme active sites by mercaptoacyldipeptides as a means to design potent dual inhibitors. Journal of Medicinal Chemistry. 39:1996;1210-1219.
24. Cox J.L., Lee E., Langer A., Armstrong P.W., Naylor C.D. Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian Medical Association Journal. 156:1997;497-505.
25. Denis L.J., Verweij J. Matrix metalloproteinase inhibitors: present achievement and future prospects. Investigational New Drugs. 14:1997;175-185.
26. Deoras P.J., Mhasalkar V.B. Antivenin activity of some snake sera. Toxicon. 1:1963;89-90.
27. Deraniyagala P.E.P. Herpetological notes. Spolia zeylan. 17:1932;44-55.
28. De Wit C. Resistance of the Prairie vole (Microtus ochrogaster) and the woodrat (Neotoma floridana), in Kansas, to venom of the Osage Copperhead (Agkistrodon contortrix phaeogaster). Toxicon. 20:1982;709-714.
29. De Wit C., Westrom B.R. Identification and characterization of trypsin, chymotrypsin and elastase inhibitors in the hedgehog, Erinaceus europaeus, and their immunological relationships to those of other mammals (rat, pig and human). Comp. Biochem. Physiol. 82A:1985;791-796.
30. De Wit C.A., Westrom B.R. Venom resistance in the hedgehog Erinaceus europaeus: purification and identification of macroglobulin inhibitors as plasma antihemorrhagic factors. Toxicon. 25:1987;315-323.
31. Domont, G.B., Perales, J., Moussatche, H., 1989. Partial purification and physico-chemical characterization of a proteic complex from Philander opossum with protective action against Bothrops jararaca venom. Brazilian-Sino Symposium on Chemistry and Pharmacology of Natural Products, 10-14 December. Rio de Janeiro, Brazil.
32. Ermolieff J., Lin X., Tang J. Kinetic properties of saquinavir-resistant mutants of human immunodeficiency virus type 1 protease and their implications in drug resistance in vivo. Biochemistry. 36:1997;12364-12370.
33. Farah M.F.L., One M., Novello J.C., Toyama M.H., Perales J., Moussatche H., Domont G.B., Oliveira B., Marangoni S. Isolation of protein factors from opossum (Didelphis albiventris) serum which protect against Bothrops jararaca venom. Toxicon. 34:1996;1067-1071.
34. Fournie-Zaluski M.C., Coric P., Thery V., Gonzalez W., Meudal H., Turcaud S., Michael J.B., Roques B.P. Design of orally active dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme with long duration of action. Journal of Medicinal Chemistry. 39:1996;2594-2608.
35. Gailit J., Clark R.A. Wound repair in the context of extracellular matrix. Curr. Opin. Cell. Biol. 6:1994;717-725.
36. Garcia V.E., Perez J.C. The purification and characterization of an antihemorrhagic factor in woodrat (Neotoma micropus) serum. Toxicon. 22:1984;129-138.
37. Giannelli G., Falk-Marzillier J., Schiraldi O., Stetler-Stevenson W.G., Quaranta V. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science. 277:1997;225-228.
38. Gomez D.E., Alonso D.F., Yoshiji H., Thorgeirsson U.P. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. European Journal of Cell Biology. 74:1997;111-122.
39. Grzimek, B., 1975. Animal Life Encyclopedia. Van Nostrand Reinhold Co., New York. p. 165.
40. Guan A.L., Retzios A.D., Henderson G.N., Markland F.S. Purification and characterization of a fibrinolytic enzyme from venom of the Southern copperhead snake (Agkistrodon contortrix contortrix). Arch. Biochem. Biophys. 289:1991;197-207.
41. Hallenberger S., Moulard M., Sordel M., Klenk H.D., Garten W. The role of eukaryotic subtilisin-like endoproteases for the activation of human immunodeficiency virus glycoproteins in natural host cells. Journal of Virology. 71:1997;1036-1045.
42. Hinton, H.E., Dunn, A.M.S., 1967. Mongooses. University of California Press, Los Angeles.
43. Huang S.Y., Perez J.C. Comparative study on hemorrhagic and proteolytic activities of snake venoms. Toxicon. 18:1980;421-426.
44. Huang S.Y., Perez J.C. A comparative electron microscopic study of myonecrosis induced by Crotalus atrox (Western Diamondback Rattlesnake) in gray woodrats and mice. Toxicon. 20:1982;443-449.
45. Jsemonger, R.M., 1962. Snakes of Africa. Southern, Central and East. Cape Town, Nelson.
46. Kellaway C.H. The immunity of Australian snakes to their own venoms. Medical Journal of Australia. 2:1931;35-52.
47. Kilmon J.A. High tolerance to snake venom by the Virginia opossum Didelphis virginiana. Toxicon. 14:1976;337-340.
48. Khokha R. Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overrexpression of the tissue inhibitor of the metalloproteinases-1. Journal of the National Cancer Institute. 86:1994;299-304.
49. Kohn E.C., Liotta L.A. Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res. 55:1995;1856-1862.
50. Korant B.D., Rizzo C.J. The HIV protease and therapies for AIDS. Advances in Experimental Medicine and Biology. 421:1997;279-284.
51. Malide D., Seidah N.G., Chretien M., Bendayan M. Electron microscopic immunocytochemical evidence for the involvement of the convertases PC1 and PC2 in the processing of proinsulin in pancreatic beta-cells. Journal of Histochemistry and Cytochemistry. 43:1995;11-19.
52. Markland F.S., Damus P.W. Purification and properties of a thrombin-like enzyme from the venom of Crotalus adamanteus (Eastern Diamondback Rattlesnake). J. Biol. Chem. 246:1971;6460-6473.
53. Markland, F.S., Reddy, K.N.N., Guan, A.L., 1988. In: Pirkle, H., Markland, F.S. (Eds.), Hemostasis and Aninal Venoms. Marcel Dekker, New York, pp. 173-189.
54. Markland F.S., Friedrichs G.S., Pewit S.R., Lucchesi B.R. Thrombolytic effects of recombinant fibrolase or APSAC in a canine model of carotid artery thrombosis. Circulation. 90:1994;2448-2456.
55. Menchaca J.M., Perez J.C. The purification and characterization of an antihemorrhagic factor in opossum (Didelphis virginiana) serum. Toxicon. 19:1981;623-632.
56. Moreno A.M., Alberola A.G., Tomas J.G., Chavarri M.V., Soria F.C., Sanchez E.M., Sanchez J.G. Incidence and prognostic significance of right bundle branch block in patients with acute myocardial infarction receiving thrombolytic therapy. International Journal of Cardiology. 61:1997;135-141.
57. Moura-Da-Silva A.M., Tanizaki M.M. Antigenic relationship among antihemorrhagic factors from snake and opossum plasmas. Braz. J. Med. Biol. Res. 22:1989;717-719.
58. Moussatche H., Yates A., Leonardi F., Borche L. Experimentos sobre la resistencia del Didelphis venezolano (Rabipelado) a los venenos de serpientes. Acta Cientifica Venezolana. 29:1978;55.
59. Moussatche H., Yates A., Leonardi F., Borche L. Mechanisms of resistance of the opossum to some snake venoms. Toxicon. 17 (Suppl. No. 1):1979;130. Abstract.
60. Moussatche H., Yates A., Leonardi F., Borche L. Obtencion de una fraccion del suero de Didelphis activa contra accion toxica del veneno de Bothrops jararaca. Acta Cient. Venezolana. 31:1980;104.
61. Moussatche, H., Leonardi, F., Mandelbaum, F., 1981. Inhibicion por una proteina aislada del suero de Didelphis marsupialis a la accion hemorragica producida por una fraccion del veneno de Bothrops jararaca. Acta Cient. Venezolana 32.
62. Moussatche H., Leonardi F. Estudios de proteccion con suero de mamiferos y reptiles a los venenos de serpientes Crotalidae. Acta Cient. Venezolana. 33:1982;151.
63. Moyle G., Gazzard B. Current knowledge and future prospects for the use of HIV protease inhibitors. Drugs. 51:1996;701-712.
64. Neves-Ferreira A.G.C., Perales J., Ovadia M., Moussatche H., Domont G.B. Inhibitory properties of the antibothropic complex from the South American opossum (Didelphis marsupialis) serum. Toxicon. 35:1997;849-863.
65. Noguchi, H., 1909. Natural immunity of certain animals from snake venom. In: Snake Venoms. Carnegie Institute, Washington, DC, p. 268.
66. Nichol A., Douglas A.V., Peck L. On the immunity of rattlesnakes to their venom. Copeia. 4:1933;211-213.
67. Ognev, S., 1962. Mammals of the USSR and Adjacent Countries. Israel Program for Scientific Translations, Jerusalem, p. 72.
68. Omori-Satoh T., Sadahiro S., Ohsaka A., Murata R. Purification and characterization of an antihemorrhagic factor in the serum of Trimeresurus flavoviridis, a crotalid. Biochim. Biophys. Acta. 285:1972;414.
69. Omori-Satoh T. Antihemorrhagic factor as a proteinase inhibitor isolated from the serum of Trimeresurus flavoviridis. Biochemica et Biophysica Acta. 495:1977;93-98.
70. Omori-Satoh T., Nagaoka Y., Mebs D. Muscle extract of hedgehog, Erinaceus europaeus, inhibits hemorrhagic activity of snake venoms. Toxicon. 32:1994;1279-1281.
71. Omori-Satoh T., Takahashi M., Nagaoka Y., Mebs D. Comparison of antihemorrhagic activities in skeletal muscle extracts from various animals against Bothrops jararaca snake venom. Toxicon. 36:1998;421-423.
72. Ovadia M., Kochva E. Neutralization of Viperidae and Elapidae snake venoms by sera of different animals. Toxicon. 15:1977;541-547.
73. Ovadia M. Purification and characterization of an antihemorrhagic factor from the serum of the snake Vipera palaestinae. Toxicon. 16:1978;661-672.
74. Perales J., Muñoz R., Moussatche H. Isolation and partial characterization of a protein fraction from the opossum (Didelphis marsupialis) serum, with protecting property against the Bothrops jararaca snake venom. An. Acad. Brasil Cienc. 58:1986;155-162.
75. Perales J., Muñoz R., Graterol S., Oviedo O., Moussatche H. New findings on the purification and characterization of an anti-bothropic factor from Didelphis marsupialis (opossum) serum. Braz. J. Med. Biol. Res. 22:1989;25-28.
76. Perales J., Amorim C.Z., Rocha S.L.G., Domont G.B., Moussatche H. Neutralization of the oedematogenic activity of Bothrops Jararaca venom on the mouse paw by an antibothropic fraction isolated from opossum (Didelphis marsupialis) serum. Agents Actions. 37:1992;250-259.
77. Perez J.C., Haws W.C., Hatch C.H. Resistance of woodrats (Neotoma micropus) to Crotalus atrox venom. Toxicon. 16:1978;198-200.
78. Perez J.C., Haws W.D., Garcia V.E., Jennings B.M. Resistance of warm-blooded animals to snake venoms. Toxicon. 16:1978;375-383.
79. Perez J.C., Pichyangkul S., Garcia V.E. The resistance of three species of warm-blooded animals to Western Diamondback rattlesnake (Crotalus atrox) venom. Toxicon. 17:1979;601-607.
80. Perry A.C., Jones R., Barker P.J., Hall L. A mammalian epididymal protein with remarkable sequence similarity to snake venom haemorrhagic peptides. Biochemical Journal. 286:1992;671-675.
81. Philpot V.B., Deutsch H.F. Inhibition and activation of venom proteases. Biochim. Biophys. Acta. 21:1956;524.
82. Phisalix C., Bertrand G. Recherches sur limmunite du herisson contre le venin de vipere. C. R. Soc. Biol. 10:1895;639-641.
83. Phisalix, C. and Bertrand, G., 1899. Sur l'immunité du hérisson contre le venin de vipère C.r. Séanc, Soc. Biol. 51, 77.
84. Pichova I., Weber J., Litera J., Konvalinka J., Vondrasek J., Soucek M., Strop P., Majer P., Heuser A.M., Kraeusslich H.G. Peptide inhibitors of HIV-1 and HIV-2 proteases: a comparative study. Leukemia. 11 (Suppl. 3):1997;120-122.
85. Pichyangkul S., Perez J.C. Purification and characterization of a naturally occurring antihemorrhagic factor in the serum of the hispid cotton rat (Sigmodon hispidus). Toxicon. 19:1981;205-215.
86. Pifano F., Aguilar I., Giron M.E., Gamboa N., Rodriguez-Acosta A. Natural resistance of opossum (Didelphis marsupialis) to the mapanare (Bothrops lanceolatus) snake venom. Rom. Arch. Microbiol. Immunol. 52:1993;131-136.
87. Poran N.S., Coss R.G., Benjamini E. Resistance of California ground squirrels (Spermophilus beecheyi) to the venom of the Northern pacific rattlesnake (Crotalus viridis oreganus): a study of adaptive variation. Toxicon. 25:1987;767-777.
88. Rael E.D., Rivas J.Z., Chen T., Maddux N., Huizar E., Lieb C.S. Differences in fibrinolysis and complement inactivation by venom from different northern blacktailed rattlesnakes (Crotalus molossus molossus). Toxicon. 35:1997;505-513.
89. Retzios A.D., Markland F.S. A direct-acting fibrinolytic enzyme from the venom of Agkistrodon contortrix contortrix: effects on various components of the human blood coagulation and fibrinolysis system. Thrombos. Res. 52:1988;541-552.
90. Retzios A.D., Markland F.S. Purification, characterization and fibrinogen cleavage sites of three fibrinolytic enzymes from the venom of Crotalus basiliscus basiliscus. Biochemistry. 31:1992;4547-4557.
91. Retzios A.D., Markland F.S. Fibrinolytic enzymes from the venoms of Agkistrodon contortrix contortrix and Crotalus basiliscus basiliscus: cleavage site specificity towards the a-chain of fibrin. Thrombos. Res. 74:1994;355-367.
92. Rodriguez-Acosta A., Aguilar I., Giron M.E. Antivenom activity of opossum (Didelphis marsupialis) serum fraction. Toxicon. 33:1995;95-98.
93. Rodriguez-Acosta A., Aguilar I., Giron M.E. Antivenom activity of opossum (Didelphys marsupialis) serum fractions (Crotalus vegrandis Klauber, 1941) venom. Rom. Arch. Microbiol. Immunol. 54:1995;325-330.
94. Sánchez, E.E., Garcia, C., Pérez, J.C., De La Zerda, S.J., 1998. The detection of hemorrhagic proteins in snake venoms using monoclonal antibodies against Virginia opossum (Didelphis virginiana) serum. Toxicon, 36, 1451 - 1459.
95. Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E., Seiki M. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 370:1994;61-65.
96. Schaeffer R.C., Carlson R.W., Puri V.K., Callahan G., Russell F.E., Weil M.H. The effects of colloidal and crystalloidal fluids on rattlesnake venom shock in the rat. Journal of Pharmacology and Experimental Therapeutics. 206:1978;687-695.
97. Schmidly, D.J., 1983. Accounts of wild animals. In: Texas Mammals East of the Balcones Fault Zone. Texas A&M Press, College Station, pp. 34-38.
98. Sledge G.W. Jr., Qulali M., Goulet R., Bone E.A., Fife R. Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice. Journal of the National Cancer Institute. 87:1995;1546-1550.
99. Smeekens S.P. Processing of protein precursors by a novel family of subtilisin-related mammalian endoproteases. Bio/Technology. 11:1993;182-186.
100. Soares A.M., Rodrigues V.M., Borges M.H., Andrião-Escarso S.H., Cunha O.A.B., Homsi-Brandeburgo M.I., Giglio J.R. Inhibition of proteases, myotoxins and phospholipases A2 from Bothrops venoms by the heteromeric protein complex of Didelphis albiventris opossum serum. Biochem. Mol. Biol. Int. 43:1997;1091-1099.
101. Soto J.G., Perez J.C., Minton S.A. Proteolytic, hemorrhagic and hemolytic activities of snake venoms. Toxicon. 26:1988;875-882.
102. Straight R.K., Glenn G.L., Snyder C.C. Antivenom activity of rattlesnake blood plasma. Nature. 261:1976;259-260.
103. Steiner D.F., Rouille Y., Gong Q., Martin S., Carroll R., Chan S.J. The role of prohormone convertases in insulin biosynthesis: evidence for inherited defects in their action in man and experimental animals. Diabetes and Metabolism. 22:1996;94-104.
104. Stewart D. The surprisingly social loner. National Wildlife. 31:1993;12-16.
105. Swanson P.L. Effects of snake venom on snakes. Copeia. 4:1946;242.
106. Tarng S.F., Huang S.Y., Perez J.C. Isolation of antihemorrhagic factors in opossum (Didelphis virginiana) serum using a monoclonal antibody immunoadsorbent. Toxicon. 24:1986;567-573.
107. Tomihara Y., Yonaha K., Nozaki M., Yamakawa M., Kamura T., Toyama S. Purification of three antihemorrhagic factors from the serum of a mongoose (Herpestes edwardsii). Toxicon. 25:1987;685-689.
108. Tomihara Y., Yonaha K., Nozaki M., Yoshita C. Neutralization of hemorrhagic snake venoms by sera of hemorrhagic snake venoms by sera of Trimeresurus flaviridis (Habu), (Herpestes edwardsii) (mongoose) and Dinodon semicarinatus (Akamata). Toxicon. 28:1990;989-991.
109. Tu A.T., Baker B., Wongvibulsin S., Willis T. Biochemical characterization of atroxase and nucleotide sequence encoding the fibrinolytic enzyme. Toxicon. 34:1996;1295-1300.
110. Vellard J. Resistencia de los 'Didelphis' (Zarigueya) a los venenos ofidicos. Rev. Braz. Biol. 5:1945;463.
111. Vellard, J., 1949. Investigaciones sobre immunidad natural contra los venenos de serpientes, vol. 1, issue 2, serie A. Publicaciones del Museo de Historia Natural, Universidade de San Marcos, Lima, Peru.
112. Weissenberg S., Ovadia M., Fleminger G., Kochva E. Antihemorrhagic factors from the blood serum of the Western diamondback rattlesnake Crotalus atrox. Toxicon. 29:1991;807-818.
113. Werner R.M., Vick J.A. Resistance of the opossum (Didelphis virginiana) to envenomation by snakes of the family Crotalidae. Toxicon. 15:1977;29-33.
114. Werner R.M., Faith R.E. Decrease in the lethal effect of snake venom by serum of the opossum, Didelphis marsupialis. Laboratory Animal Science. 28:1978;710-713.
115. White H.D., Aylward P.E., Frey M.J., Adgey A.A., Nair R., Hillis W.S., Shalev Y., Brown M.A., French J.K., Collins R., Maraganore J., Adelman B. Randomized, double-blind comparison of hirulog versus. Circulation. 96:1997;2155-2161.
116. Yates A., Moussatche H., Leonardi F., Borche L. Aislamiento de la fraccion del suero de Didelphis (Rabipelado) protectora contra la toxicidade del veneno de Bothrops jararaca. Acta Cient. Venezolana. 30:1979;54.